Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

Not Applicable

Completed

• Conditions: Anxiety; Depression

• Registration Number: NCT03496350
• Lead Sponsor: Linkoeping University

Brief Summary

The purpose of this study is to evaluate the efficacy of a culturally adapted internet-administrated cognitive behaviour therapy (ICBT) in Arabic for anxiety and depression

Detailed Description

The study will compare the effect of the intervention against a wait-list control. The intervention tested is based on cognitive behavior therapy delivered over the internet via a secure treatment platform. Participants in the study are recruited from the general public via social media. The intervention is in Arabic.

Study Timeline

• Study First Submitted: 2018-03-29
• Study First Submitted QC: 2018-04-05
• Study First Posted: 2018-04-12
• Study Start: 2019-01-07
• Primary Completion: 2019-12-01
• Study Completion: 2019-12-01
• Status Verified: 2020-02
• Last Update Submitted: 2020-02-19
• Last Update Posted: 2020-02-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 59

Inclusion Criteria

• Be above 18 years of age
• Have symptoms of anxiety and/or depression
• Be able to read and write in Arabic
• Have access to computer or smartphone

Exclusion Criteria

• Suicidal ideation
• Alcohol addiction
• Other major primary psychiatric disorder
• Ongoing psychological treatment
• Recent (during last 4 weeks) change in psychiatric medication

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Generalised Anxiety Disorder-7-item scale, (GAD-7)	pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment	The GAD-7 is a seven-item self-report questionnaire that measures symptoms of anxiety. It is scored from 0-21 with a higher score reflecting more severe symptoms.
Change in Patient Health Questionnaire (PHQ-9)	pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment	The PHQ-9 is a nine-item self-report questionnaire that measures symptoms of depression. It is scored from 0-27 with a higher score reflecting more severe symptoms.

Secondary Outcome Measures

Name	Time	Method
Insomnia Severity Index (ISI)	pre-treatment, week 8	Self-reported symptoms of insomnia. It is scored from 0-28 with higher scores reflecting more symptoms of insomnia.
Impact of Events Scale - Revised (IES-R)	pre-treatment, week 8	Self-reported symptoms of post-traumatic stress. It is scored from 0-88 where higher scores reflect more symptoms.
Perceived Stress Scale (PSS)	pre-treatment, week 8	Self-reported stress-related symptoms. It is scored from 0-56 with higher scores reflecting more symtoms of perceived stress.
"Brunnsviken Brief Quality of Life Scale" (BBQ)	pre-treatment, week 8	Self-reported quality of life. The scale is scored from 0-96 with a higher score reflecting higher self-reported quality of life.
Alcohol Use Disorder Identification Test (AUDIT)	pre-treatment, week 8	Measures alcohol consumption, drinking behaviors, and alcohol-related problems. It is scored from 0-40 with higher scores reflecting more alcohol consumption, drinking behaviors, and alcohol-related problems.

Trial Locations

Locations (1)

Linköping University; 🇸🇪 Linköping, Sweden